REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Anti-CMV Total

SARS-CoV-2

Toxoplasma IgG

Toxoplasma IgM

West Nile Virus NAT

Zika NAT

HIV/HCV/HBV NAT

SARS-CoV-2

Syphilis (RPR)

CMV IgG

CMV IgM

EBV IgG